PA
CEPT

PharVision Advisers’s Cantor Equity Partners II CEPT Stock Holding History

PharVision Advisers’s Portfolio CEPT Stock Details CEPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,666
Closed -$154K – 696
2025
Q4 		$154K Buy
+13,666
New +$154K 0.08% 609

Other funds holding CEPT

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
HCI
Harraden Circle Investments New York $784M AUM 20.59% 1-Year Est. Return
GL
Governors Lane New York $1.2B AUM 26.21% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
DAM
DLD Asset Management New York $1.51B AUM 5.32% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
FLC
Fifth Lane Capital Austin, Texas $1.63M AUM 7.3% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

PharVision Advisers's CEPT Position: Q1 2026 in Review

PharVision Advisers sold out of Cantor Equity Partners II (CEPT) in Q1 2026, closing a stake of 13,666 shares — an estimated $154K sold.

PharVision Advisers first reported a position in CEPT in Q4 2025 and held it in 1 quarter. The position peaked at $154K in Q4 2025. 72 funds tracked by Wall St. Rank hold CEPT as of Q1 2026.

  • PharVision Advisers reported no remaining Cantor Equity Partners II position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 13,666 Cantor Equity Partners II shares in Q1 2026, an estimated $154K.
  • PharVision Advisers first reported a position in Cantor Equity Partners II in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's Cantor Equity Partners II position peaked at $154K in Q4 2025.
  • 72 funds tracked by Wall St. Rank held Cantor Equity Partners II as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.